Amanote Research
Register
Sign In
Clofarabine Combinations as Acute Myeloid Leukemia Salvage Therapy
Cancer
- United States
doi 10.1002/cncr.23816
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
October 15, 2008
Authors
Stefan Faderl
Alessandra Ferrajoli
William Wierda
Xuelin Huang
Srdan Verstovsek
Farhad Ravandi
Zeev Estrov
Gautam Borthakur
Monica Kwari
Hagop M. Kantarjian
Publisher
Wiley
Related search
Clofarabine Salvage in Refractory Acute Myeloid Leukemia Before Allogeneic Stem Cell Tranplant
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Epigenetic Therapy Combinations in Acute Myeloid Leukemia: What Are the Options?
Therapeutic Advances in Hematology
Hematology
“Epigenetic” Modification as Therapy for Acute Myeloid Leukemia
Cancer
Cancer Research
Oncology
Clofarabine, Idarubicin, and Cytarabine (CIA) as Frontline Therapy for Patients <= 60 Years With Newly Diagnosed Acute Myeloid Leukemia (AML)
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Therapy of Acute Myeloid Leukemia
Therapy-Related Myelodysplasia and Acute Myeloid Leukemia
Seminars in Oncology
Oncology
Hematology
Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia
Clinical Hematology International
Phase II Trial of Clofarabine and Daunorubicin as Induction Therapy for Acute Myeloid Leukemia Patients Greater Than or Equal to 60 Years of Age
Leukemia Research
Cancer Research
Oncology
Hematology
Acute Myeloid Leukemia Therapy and the Chosen People
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology